Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Treasury Shares (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Treasury Shares for 4 consecutive years, with $300.0 as the latest value for Q3 2024.

  • On a quarterly basis, Treasury Shares fell 1.64% to $300.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $300.0, a 1.64% decrease, with the full-year FY2023 number at $305000.0, up 93746.15% from a year prior.
  • Treasury Shares was $300.0 for Q3 2024 at Actinium Pharmaceuticals, down from $305.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $881000.0 in Q4 2021 to a low of $300.0 in Q3 2024.
  • A 4-year average of $251985.0 and a median of $152652.5 in 2023 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: tumbled 63.11% in 2022, then decreased 1.64% in 2024.
  • Actinium Pharmaceuticals' Treasury Shares stood at $881000.0 in 2021, then crashed by 63.11% to $325000.0 in 2022, then decreased by 6.15% to $305000.0 in 2023, then tumbled by 99.9% to $300.0 in 2024.
  • Per Business Quant, the three most recent readings for ATNM's Treasury Shares are $300.0 (Q3 2024), $305.0 (Q2 2024), and $305000.0 (Q4 2023).